Sarcoma
Cyrus Sholevar, MD
Resident Physician
UC Davis Medical Center, United States
Cyrus Sholevar, MD
Resident Physician
UC Davis Medical Center, United States
Cyrus Sholevar, MD
Resident Physician
UC Davis Medical Center, United States
Sylvia Cruz, BS
Medical Student
UC Davis Medical Center, United States
Sean J. Judge, MD, MS
Fellow
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Marshall Lammers, BS
PhD Candidate
UC Davis Medical Center, United States
Morgan Darrow, MD
Professor
UC Davis Medical Center, United States
Khurshid Iranpur, BS
Research Specialist
UC Davis Medical Center, United States
Lauren Farley, BS
Research Specialist
UC Davis Medical Center, United States
Arta Monjazeb, MD, PhD
Professor
UC Davis Medical Center, United States
Steven W. Thorpe, MD
Professor
UC Davis Medical Center, California, United States
Lihong Qi, PhD
Professor
UC Davis Medical Center, United States
William Murphy, PhD
Professor
UC Davis Medical Center, United States
Robert J. Canter, MD
Professor
UC Davis Medical Center
Sacramento, California, United States
We have previously observed improved survival in soft tissue sarcoma (STS) patients who harbor greater numbers of intratumoral natural killer (NK) cells. However, the impact of immune-modifying variables such as obesity on immune infiltrates in STS is not well-defined. Here, we sought to investigate the relationship between BMI and NK cell populations in the blood and tumor of STS patients.
Methods:
On an IRB-approved protocol, blood and tumor specimens were prospectively collected on 31 STS patients undergoing surgery from 2018 – 2023. Clinical and demographic data were abstracted from the medical record, and specimens were processed for immune phenotyping by flow cytometry. Parametric and non-parametric statistics were used to analyze for associations with outcomes.
Results:
86% of patients were AJCC stage 3, 52% of tumors were located on the extremity, and 33% were retroperitoneal. 81% received preoperative radiotherapy, and the median BMI was 27 (range, 18.4 - 39.4). With a median follow up of 24.4 months, median metastasis free survival was 12.6 months (2.0 - 45.7), and median overall survival was 24.4 months (5.9 - 75.6). Overall, NK cells were approximately 55-fold more frequent in the blood (per mm3) than tumor (per mg, P< 0.05). The frequency of cytotoxic CD56dim NK cells of total NK cells was also greater in the blood than tumor (91.7% ± 5.35 blood vs. 82.4% ± 12.5 tumor, P = 0.0001). Increasing BMI was significantly associated with lower intratumoral NK cells (r = -0.46, P = 0.048) and lower intratumoral CD56dim NK cells (r = -0.51, P = 0.03). When stratifying by lean (BMI < 25) versus obese (BMI ≥ 30), lean patients had a greater proportion of CD56dim NK cells in the peripheral blood compared to obese (94.0% vs 89.4%, P = 0.014) as well as approximately 9-fold greater intratumoral CD56dim NK cells compared to obese (P = 0.02). When stratifying by the median BMI of 27, there was a trend for improved overall survival among lower BMI patients (P=0.08)
Conclusions:
Obesity is associated with differences in numbers and phenotype of NK cell infiltrates in STS patients undergoing surgery. Obesity-induced NK dysfunction may be prognostically relevant in STS.